Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Vey

Showing results (121-130 of 251) with videos related to

Pageof 26
Sort By:
Experimental Hematology|February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapyClaude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
British Journal of Haematology|April 22, 2005
One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remissionEric Jourdan, Françoise Rigal-Huguet, Gerald Marit, et al.
British Journal of Haematology|April 25, 2009
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaVéronique Gelsi-Boyer, Virginie Trouplin, José Adélaïde, et al.
Hematology (Amsterdam, Netherlands)|May 3, 2023
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphomaRobin Noel, Christophe Zemmour, Catalina Montes de Oca, et al.
Journal De Mycologie Medicale|January 24, 2026
Pronostic factors for survival in candidemia among onco-hematology patients: a single-center retrospective study during 10 yearsFlorian Cardona, Ferdinand Villetard, Christophe Zemmour, et al.
Cancer Research|March 11, 2016
Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia PatientsEmmanuel Griessinger, Fernando Anjos-Afonso, Jacques Vargaftig, et al.
European Journal of Haematology|January 6, 2025
Outcomes of Elderly Patients Admitted to the Intensive Care Unit for Newly Diagnosed Acute Myeloid LeukemiaGuillaume Berton, Marie-Anne Hospital, Sylvain Garciaz, et al.
Clinical Hematology International|December 23, 2021
The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute's ExperienceDidier Blaise, Pierre Berger, Djamel Mokart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantationRaynier Devillier, Samia Harbi, Sabine Fürst, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Pageof 26

Showing results (121-130 of 251) with videos related to

Sort By:
Pageof 26
Experimental Hematology|February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapyClaude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
British Journal of Haematology|April 22, 2005
One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remissionEric Jourdan, Françoise Rigal-Huguet, Gerald Marit, et al.
British Journal of Haematology|April 25, 2009
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaVéronique Gelsi-Boyer, Virginie Trouplin, José Adélaïde, et al.
Hematology (Amsterdam, Netherlands)|May 3, 2023
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphomaRobin Noel, Christophe Zemmour, Catalina Montes de Oca, et al.
Journal De Mycologie Medicale|January 24, 2026
Pronostic factors for survival in candidemia among onco-hematology patients: a single-center retrospective study during 10 yearsFlorian Cardona, Ferdinand Villetard, Christophe Zemmour, et al.
Cancer Research|March 11, 2016
Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia PatientsEmmanuel Griessinger, Fernando Anjos-Afonso, Jacques Vargaftig, et al.
European Journal of Haematology|January 6, 2025
Outcomes of Elderly Patients Admitted to the Intensive Care Unit for Newly Diagnosed Acute Myeloid LeukemiaGuillaume Berton, Marie-Anne Hospital, Sylvain Garciaz, et al.
Clinical Hematology International|December 23, 2021
The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute's ExperienceDidier Blaise, Pierre Berger, Djamel Mokart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantationRaynier Devillier, Samia Harbi, Sabine Fürst, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Pageof 26